Antipsychotic drug side effects for persons with intellectual disability

Johnny L Matson; Sara Mahan

doi:10.1016/j.ridd.2010.05.005

Antipsychotic drug side effects for persons with intellectual disability

Res Dev Disabil. 2010 Nov-Dec;31(6):1570-6. doi: 10.1016/j.ridd.2010.05.005. Epub 2010 Jun 26.

Authors

Johnny L Matson¹, Sara Mahan

Affiliation

¹ Department of Psychology, Louisiana State University, Baton Rouge, LA 70803, USA. johnmatson@aol.com

PMID: 20580203
DOI: 10.1016/j.ridd.2010.05.005

Abstract

Antipsychotic drugs are the most frequently prescribed of the psychotropic drugs among the intellectually disabled (ID) population. Given their widespread use, efforts to systematically assess and report side effects are warranted. Specific scaling methods such as the Matson Evaluation of Side Effects (MEDS), the Abnormal Inventory Movement Scale (AIMS), and Dyskinesia Identification System Condensed User Scale (DISCUS) are reviewed. Symptom patterns and a focus on additional research are discussed. While progress has been made, more and more systematic methods to research these problems are necessary.

Publication types

Review

MeSH terms

Antipsychotic Agents / adverse effects*
Humans
Intellectual Disability / drug therapy*
Intellectual Disability / epidemiology
Movement Disorders / diagnosis*
Movement Disorders / epidemiology
Movement Disorders / etiology*
Prevalence
Risk Factors

Substances

Antipsychotic Agents